Literature DB >> 18161657

Matrix metalloproteinase-19 is a predictive marker for tumor invasiveness in patients with oropharyngeal squamous cell carcinoma.

N Velinov1, D Aebersold, N Haeni, R Hlushchuk, G Mishev, F Weinstein, R Sedlacek, V Djonov.   

Abstract

AIMS: To evaluate the expression of matrix metalloproteinase-19 (MMP-19) in oropharyngeal squamous cell carcinoma along with its association with structural features of invasiveness. To investigate whether MMP-19 expression correlates with lymphatic or systemic metastasis and prognosis in patients who have received definitive radiotherapy. METHODS AND
RESULTS: The histological evaluation of the invasive front was based on Bryne's malignancy grading system. We correlated the immunohistochemical expression pattern with morphological parameters which characterize tumor invasiveness such as keratinization, nuclear polymorphism, invasion pattern, and the host inflammatory response. Local immunoreactivity for MMP-19 was positively correlated with tumor invasiveness as reflected in its structural characteristics and the degree of nuclear polymorphism, and negatively correlated with the inflammatory response of the host. No correlation existed between MMP-19 expression and clinicopathological features (TNM stage, grade of differentiation) or a patient''s outcome and prognosis.
CONCLUSIONS: This latter finding probably reflects the unique change for MMPs from high immunoreactivity within healthy tissue areas and non-invasive tumor parts, through absence in the least invasive neoplastic regions, to strong re-expression at a highly invasive front of the same tumor. Our findings indicate that MMP-19 can be used as a marker for tumor invasiveness in patients with oropharyngeal squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18161657

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   2.659


  6 in total

1.  Overexpression of asparagine synthetase and matrix metalloproteinase 19 confers cisplatin sensitivity in nasopharyngeal carcinoma cells.

Authors:  Ran-Yi Liu; Zizheng Dong; Jianguo Liu; Ling Zhou; Wenlin Huang; Sok Kean Khoo; Zhongfa Zhang; David Petillo; Bin Tean Teh; Chao-Nan Qian; Jian-Ting Zhang
Journal:  Mol Cancer Ther       Date:  2013-08-16       Impact factor: 6.261

2.  Matrix metalloproteinases and angiogenic factors: predictors of survival after radical prostatectomy for clinically organ-confined prostate cancer?

Authors:  Silvan Boxler; Valentin Djonov; Thomas M Kessler; Ruslan Hlushchuk; Lucas M Bachmann; Ulrike Held; Regula Markwalder; George N Thalmann
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

Review 3.  miRNA-486-5p: signaling targets and role in non-malignant disease.

Authors:  Adrianna Douvris; Jose Viñas; Kevin D Burns
Journal:  Cell Mol Life Sci       Date:  2022-06-22       Impact factor: 9.207

4.  Co-expression of MMP-14 and MMP-19 predicts poor survival in human glioma.

Authors:  Liang Wang; Jun Yuan; Yanyang Tu; Xinggang Mao; Shiming He; Guoqiang Fu; Jianhai Zong; Yongsheng Zhang
Journal:  Clin Transl Oncol       Date:  2012-07-19       Impact factor: 3.405

5.  Orthotopic Glioblastoma Models for Evaluation of the Clinical Target Volume Concept.

Authors:  Rebecca Bütof; Pia Hönscheid; Rozina Aktar; Christian Sperling; Falk Tillner; Treewut Rassamegevanon; Antje Dietrich; Matthias Meinhardt; Daniela Aust; Mechthild Krause; Esther G C Troost
Journal:  Cancers (Basel)       Date:  2022-09-20       Impact factor: 6.575

6.  Matrix metalloproteinases: the gene expression signatures of head and neck cancer progression.

Authors:  Shinji Iizuka; Naozumi Ishimaru; Yasusei Kudo
Journal:  Cancers (Basel)       Date:  2014-02-13       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.